BIOPHARMA 2024: NAVIGATING THE PATENT CLIFF – OPPORTUNITIES AND CHALLENGES

Join us for our next Life Sciences roundtable where we will explore the rapidly changing landscape in the pharmaceutical industry as a multitude of blockbuster drugs approach their patent expiration. With a focus on the Philadelphia market, this event delves into the dynamic environment that both established biopharma leaders and emerging players face. Attendees will gain insights into navigating the evolving landscape of big pharma investments and mergers & acquisitions, identifying key opportunities, and addressing challenges in the current scenario. Experts will discuss how these industry shifts have nationwide significance and specifically impact the Philadelphia market, providing strategies for players to effectively capitalize on the unfolding trends.

Speakers:

• Kathleen Brunner, President & CEO, Acumen Analytics
• Matthew L. Fedowitz, Shareholder, Life Sciences, Buchanan Ingersoll & Rooney PC
• Brian Winne, Life Sciences Senior Analyst, Senior Manager, RSM
• Tom Evegan, Principal, Strategy & Management Consulting, RSM (Moderator)

Thank you to our event sponsor:

• RSM